Every 8-K that Celanese Corp Del (CE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CE filings page.
Celanese Corporation reported second quarter 2026 adjusted earnings per share of $2.45, including about $0.35 per share of non-cash transaction amortization, its highest level in nearly three years. Companywide operating EBITDA grew by more than 20% versus the prior-year period.
Engineered Materials delivered adjusted EBIT of $234 million and operating EBITDA of $335 million, with margins of 16% and 23%. Growth platforms performed strongly, with medical net sales up 19% and electronics up 11% year-over-year, while portfolio and footprint actions are expected to drive about $30 million of annualized cost savings and double-digit full-year adjusted EBIT growth despite inventory and divestiture headwinds.
The Acetyl Chain generated adjusted EBIT of $321 million and operating EBITDA of $385 million, at margins of 24% and 29%, as net sales rose 28% sequentially and 19% year-over-year, led by Western Hemisphere vinyl chain strength. Free cash flow was $140 million in the quarter, and management now targets 2026 free cash flow of $700–$800 million. The company repaid $508 million and $400 million of 2026 bonds using cash on hand and ended the quarter with total debt of $12.0 billion and net debt of $10.6 billion. Third quarter 2026 adjusted EPS is guided to approximately $1.35–$1.75, with full-year adjusted EPS expected to be about $6.00.
Celanese Corporation reported strong second quarter 2026 results, with net sales of $2,752 million and U.S. GAAP diluted earnings per share of $1.15 and adjusted earnings per share of $2.45, its highest adjusted EPS in nearly three years. Net sales increased 18 percent sequentially, driven by a 4 percent volume increase and a 14 percent price increase. Consolidated operating profit was $276 million, adjusted EBIT $470 million, and operating EBITDA $649 million, at margins of 10, 17, and 24 percent, respectively.
Engineered Materials delivered net sales of $1,446 million and operating EBITDA of $335 million with a 23 percent margin, supported by favorable pricing and mix and growth in medical and electronics. The Acetyl Chain generated net sales of $1,329 million and operating EBITDA of $385 million with a 29 percent margin, reflecting pricing and volume gains. Portfolio and footprint actions, including the Ulsan compounding closure, nylon 6,6 optimization, and planned Lanaken acetate tow closure, are expected to provide more than $50 million of annualized fixed-cost savings.
Operating cash flow for the quarter was $209 million and free cash flow was $140 million. Cash and cash equivalents totaled $1,364 million against total debt of $12,007 million, with net debt of $10,643 million as deleveraging remains a priority. For the third quarter, management projects adjusted EPS of approximately $1.35 to $1.75, and for full year 2026 it continues to expect about $6.00 of adjusted EPS and $700 to $800 million of free cash flow.
Celanese Corporation reports that its wholly owned subsidiary Celanese US Holdings LLC entered into a First Amendment to its Revolving Credit Agreement dated August 11, 2025. The amendment applies from the fiscal quarter ending March 31, 2027 through the facility’s maturity.
The amendment increases the consolidated net leverage ratio financial covenant level to 5.50:1.00, with modified step‑down levels thereafter. It also increases the combined negative covenant baskets for debt incurred by foreign subsidiaries for acquisitions and by Chinese subsidiaries for corporate purposes from $900 million to $1,050 million, and makes additional technical changes.
Celanese Corporation, through its wholly owned subsidiary Celanese US Holdings LLC, has initiated the redemption of all outstanding 4.777% Senior Notes due July 19, 2026. The company issued a formal notice of redemption under the governing indenture.
The redemption is expected to occur on June 25, 2026. Holders will receive a redemption price equal to 100% of the principal amount of the Notes being redeemed, plus any accrued and unpaid interest up to the redemption date.
Celanese Corporation reported first quarter 2026 adjusted earnings per share of $0.85, reflecting solid execution in a weak demand environment. Engineered Materials delivered adjusted EBIT of $220 million and operating EBITDA of $324 million, helped by favorable mix, cost reductions and value‑based pricing.
The Acetyl Chain generated adjusted EBIT of $131 million and operating EBITDA of $194 million, with late‑quarter supply disruptions creating high‑value pricing opportunities that are expected to benefit second quarter results. Company‑wide free cash flow was $3 million, an improvement versus typical seasonal cash use.
Management raised its full‑year 2026 free cash flow target to $700–$800 million and continues to prioritize deleveraging, with net debt of $10.8 billion at quarter‑end and plans to repay roughly $900 million of bonds in the second and third quarters. For the second quarter, Celanese guides to adjusted EPS of $2.00–$2.40, driven primarily by stronger Acetyl Chain earnings, and expects second quarter to be the highest‑earning quarter of 2026.
Celanese Corporation reported stronger first quarter 2026 results, with improving earnings and cash flow. U.S. GAAP diluted EPS from continuing operations was $0.41 and adjusted EPS was $0.85. Net sales were $2.34 billion, up 6% sequentially, driven mainly by 5% higher volumes.
Engineered Materials delivered $1.3 billion of net sales and operating EBITDA of $324 million, with margins of 25%. The Acetyl Chain generated $1.0 billion of net sales and $194 million of operating EBITDA at a 19% margin. Companywide operating EBITDA reached $455 million.
Free cash flow was modest at $3 million, reflecting seasonal working capital and timing of interest payments, but management raised its full‑year free cash flow outlook to $700–$800 million and targets a net debt to operating EBITDA ratio near 4.8x. The company also outlined Q2 2026 adjusted EPS guidance of $2.00–$2.40 and projected about $3.00 of adjusted EPS in the second half of 2026.
Celanese Corporation expanded its Board of Directors from nine to 10 members and elected Anne P. Noonan as a director, effective April 20, 2026. She will serve until the 2027 Annual Meeting of Shareholders, when she is expected to stand for election by shareholders.
The Board determined that Ms. Noonan is an independent director under SEC and NYSE standards and is not related to any company officers or directors. A former CEO of Summit Materials and OMNOVA Solutions with more than 30 years of industry experience, she will receive standard non-management director compensation.
Celanese Corporation reported the results of its 2026 Annual Meeting of Shareholders. Nine director nominees were elected to terms expiring at the 2027 annual meeting, each receiving strong support, with votes for individual nominees generally exceeding 91.6 million shares.
Shareholders ratified the selection of KPMG LLP as independent registered public accounting firm for 2026, with 97,496,875 votes for and limited opposition. An advisory vote on executive compensation also passed, receiving 91,098,487 votes for versus 1,766,137 against. Of 111,922,758 shares entitled to vote as of February 23, 2026, 99,090,064 were represented in person or by proxy, reflecting an 88.53% quorum.
Celanese Corporation reported that on February 27, 2026, Timothy Go resigned from its Board of Directors, effective the same day. The company states that his resignation was not due to any disagreement regarding operations, policies, or practices. The Board and the company expressed appreciation for his service as a director.
Celanese Corporation reported solid 2025 cash-generation despite a weak demand backdrop. The company delivered full-year 2025 adjusted earnings per share of $3.98 and operating EBITDA of $1.9 billion. Free cash flow reached $773 million, more than 50 percent higher than 2024, driven by cost reductions, working capital releases and disciplined spending.
Engineered Materials produced 2025 adjusted EBIT of $720 million and operating EBITDA of $1.2 billion at margins of 13 percent and 22 percent. The Acetyl Chain generated adjusted EBIT of $695 million and operating EBITDA of $947 million, also at 16–22 percent margins. Fourth-quarter 2025 adjusted EPS was $0.67, with free cash flow of $160 million.
Celanese refinanced about $4 billion of debt, cutting 2026–2027 maturities from $4.8 billion to $2.1 billion, and closed the Micromax® divestiture for $492 million in cash. For 2026, the company targets free cash flow of $650–$750 million, $50–$70 million of additional cost savings, and first‑quarter adjusted EPS of $0.70–$0.85, while continuing to prioritize deleveraging.
Celanese Corporation reported a challenging 2025 with a large GAAP loss but solid cash generation. Full-year 2025 U.S. GAAP diluted loss per share was $10.44, while adjusted earnings per share were $3.98. Net sales were $9.5 billion, down 7% from the prior year, driven by lower prices and volumes in key end markets.
The company posted a 2025 operating loss of $786 million, but adjusted EBIT reached $1.15 billion and operating EBITDA was $1.89 billion. Free cash flow was $773 million, helped by cost reductions, lower capital spending, and inventory reductions. A $1.1 billion goodwill impairment in Engineered Materials was a major factor behind the GAAP loss.
In the fourth quarter, Celanese delivered U.S. GAAP diluted earnings per share of $0.23 and adjusted earnings per share of $0.67 on net sales of $2.2 billion, a sequential 9% decline as volumes softened. Management expects first-quarter 2026 adjusted earnings per share of $0.70 to $0.85 and targets 2026 free cash flow of $650 million to $750 million while continuing deleveraging and cost-saving initiatives.
Celanese Corporation reported that Director Scott M. Sutton resigned from its Board of Directors effective January 4, 2026. He stepped down because of the expected responsibilities and time commitment required for his new role as Chief Executive Officer of Rayonier Advanced Materials Inc. The company states that his resignation is not due to any disagreement with Celanese regarding its operations, policies, or practices.
The Board acknowledges Mr. Sutton’s numerous contributions during his tenure and extends well wishes for his new position. Celanese also issued a press release on January 6, 2026, to publicly announce his resignation.
Celanese Corporation reports that its wholly owned subsidiary Celanese US Holdings LLC has completed a registered debt offering of $600,000,000 of 7.000% Senior Notes due 2031 and $800,000,000 of 7.375% Senior Notes due 2034.
The notes are senior unsecured obligations of the issuer and are guaranteed on a senior unsecured basis by Celanese Corporation and, initially, certain subsidiary guarantors. Interest will be paid semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2026.
Net proceeds from the offering, together with available cash, will be used to repay borrowings under Celanese’s five-year term loan credit agreement due 2027, to fund previously announced and upsized cash tender offers for approximately $1.2 billion of existing 6.665% notes due 2027 and 6.850% notes due 2028, and for general corporate purposes, which may include repaying other outstanding indebtedness.
Celanese Corporation reported that on December 16, 2025 it issued a press release detailing the early results and increase in size of its previously announced cash tender offers for two series of senior notes. The company is conducting cash tender offers to purchase up to an aggregate principal amount of $946,106,000 of its 6.665% Senior Notes due 2027 and up to $254,000,000 of its 6.850% Senior Notes due 2028. The filing mainly updates investors on the status and enlarged maximum size of these debt repurchase transactions.
Celanese Corporation announced that its subsidiary Celanese US Holdings LLC entered into an underwriting agreement for a new senior notes offering. The Issuer agreed to sell $600,000,000 aggregate principal amount of 7.000% Senior Notes due 2031 and $800,000,000 aggregate principal amount of 7.375% Senior Notes due 2034. The transaction is being conducted through a registered public offering under an existing shelf registration statement on Form S-3, using a prospectus, a related prospectus supplement dated December 2, 2025, and a free writing prospectus filed on December 3, 2025.
Celanese Corporation announced that its wholly owned subsidiary Celanese US Holdings LLC has launched cash tender offers to buy back up to an aggregate principal amount of $1,000,000,000 of its outstanding senior notes. The offers target its 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028.
The 2028 notes are subject to a series cap, limiting purchases of that issue to a maximum aggregate principal amount of $100,000,000. The tender offers are being made on the terms and conditions described in an Offer to Purchase dated December 2, 2025, and represent a step in managing the company’s outstanding debt profile and interest-bearing obligations.
Celanese Corporation announced a Regulation FD webcast for investors and analysts on November 7, 2025 at 9:00 a.m. ET to discuss its third quarter 2025 results. CEO Scott A. Richardson will present, with materials available at investors.celanese.com under News & Events.
The company furnished exhibits including prepared remarks and a slide presentation (Exhibits 99.1(a) and 99.1(b)). Non‑US GAAP measures referenced in the remarks are defined and reconciled to the most comparable US GAAP metrics in Exhibit 99.2. These materials are furnished, not filed.
Celanese Corporation (CE) furnished an 8-K announcing it issued a press release reporting financial results for the third quarter of 2025. The press release is provided as Exhibit 99.1.
Non‑US GAAP measures referenced in the release are reconciled to the most comparable US GAAP measures in Exhibit 99.2. The information was furnished under Item 2.02 and is not deemed filed under the Exchange Act.
Celanese Corporation announced it signed a purchase and sale agreement with Element Solutions Inc to divest the Company’s Micromax® portfolio of products. The closing is described as being subject to regulatory approval and other closing conditions.
The Company furnished a press release as Exhibit 99.1 and included forward‑looking statements referencing expected timing, future performance, and deleveraging efforts. The disclosure was furnished under Regulation FD and is not deemed filed for liability purposes.
Celanese Corporation announced its intent to close its acetate tow facility in Lanaken, Belgium to streamline production costs across its global network. The company plans to permanently cease manufacturing operations in the second half of 2026, subject to a consultation process with the facility’s works council and union representatives.
Celanese expects total expenses of $70–90 million, including $55–65 million of non-cash accelerated depreciation of fixed assets and $15–25 million of other shutdown cash costs. The company expects cash outflows related to these actions during fiscal years 2026 through 2028. Employee termination costs will be determined following the consultation and disclosed afterward. Actual charges may vary depending on the consultation outcome.
Celanese Corporation entered into a five-year unsecured Revolving Credit Agreement providing a $1.75 billion facility with a $250 million sublimit for letters of credit, replacing its prior revolver. The facility is available in U.S. dollars and certain other currencies and is guaranteed by the company, Celanese US Holdings LLC and certain domestic subsidiaries.
Borrowings accrue interest based on Daily Simple SOFR, Term SOFR or a customary base rate plus a margin of 1.00%–2.00% (or 0.00%–1.00% for U.S. dollar base rate borrowings), with undrawn amounts subject to a commitment fee of 0.09%–0.35%, each range tied to the company’s senior unsecured debt ratings. The agreement includes customary covenants—maintenance of a leverage ratio and a fixed charge coverage ratio—limits on dividends until a target ratio is met, and customary default provisions. Separately, Celanese US agreed to a Sixth Amendment to its Term Loan Credit Agreement adding a minimum consolidated fixed charge coverage ratio and similar dividend limitations. Full terms are in Exhibits 10.1 and 10.2.
Celanese Corporation announced that its President and CEO, Scott A. Richardson, will present the company’s second quarter 2025 financial results in a webcast on August 12, 2025 at 9:00 a.m. ET. The company says the webcast, a press release, management's prepared remarks and a slide presentation will be available on the Celanese investor website under News & Events/Events Calendar.
The filing furnishes the prepared remarks and slide deck as Exhibit 99.1(a) and Exhibit 99.1(b), and provides a Non-US GAAP Financial Measures and Supplemental Information document as Exhibit 99.2 that defines and reconciles the non-GAAP measures referenced by management. The company notes these materials are being furnished, not filed, and therefore are not subject to Section 18 liabilities or incorporation by reference.
Celanese Corporation filed a Current Report on Form 8-K stating that on August 11, 2025 the company issued a press release reporting its second quarter 2025 financial results, which is furnished as Exhibit 99.1. The filing also furnishes Exhibit 99.2, which reconciles each Non‑US GAAP financial measure in the press release to the most directly comparable US GAAP measure and provides supplemental information explaining management's view of those measures.
The disclosure is provided pursuant to Item 2.02 (results of operations) and Item 9.01 (furnished exhibits). The filing states that the information and exhibits will not be incorporated by reference into other filings under the Securities Act or the Exchange Act.